Jaguar Health (JAGX) Depreciation & Amortization (CF) (2016 - 2026)

Jaguar Health (JAGX) has 11 years of Depreciation & Amortization (CF) data on file, last reported at $473000.0 in Q1 2026.

• On a quarterly basis, Depreciation & Amortization (CF) fell 1.25% year-over-year to $473000.0 in Q1 2026; TTM through Mar 2026 was $1.9 million, a 1.54% increase from a year earlier, with the FY2025 full-year figure at $1.9 million, up 0.68% from the prior year.
• Depreciation & Amortization (CF) for Q1 2026 stood at $473000.0, down from $477000.0 in the prior quarter.
• Over the last five years, Depreciation & Amortization (CF) for JAGX reached as high as $558000.0 in Q2 2022 and fell as low as $426000.0 in Q1 2022.
• Historically, Depreciation & Amortization (CF) has averaged $487058.8 across 5 years, with a median of $479000.0 in 2025.
• Across the five-year window, Depreciation & Amortization (CF) increased 29.77% in 2022 and slipped 11.13% in 2024, its largest moves.
• Year by year, Depreciation & Amortization (CF) stood at $499000.0 in 2022, then increased by 0.6% to $502000.0 in 2023, then dropped by 4.78% to $478000.0 in 2024, then decreased by 0.21% to $477000.0 in 2025, then retreated by 0.84% to $473000.0 in 2026.
• Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $473000.0 in Q1 2026, $477000.0 in Q4 2025, and $479000.0 in Q3 2025.